Advertisement
Screener

PharMerica CORP Form 8-K: Current report, 2009

PharMerica CORP Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2009-11-23: Form 8-K; Period of report 2009-11-17; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 5.02.
  • 2009-10-29: Form 8-K; Period of report 2009-10-29; Description 2.02 Results of Operations and Financial Condition.
  • 2009-08-03: Form 8-K; Period of report 2009-08-03; Description 2.02 Results of Operations and Financial Condition.
  • 2009-04-30: Form 8-K; Period of report 2009-04-30; Description 2.02 Results of Operations and Financial Condition.
FiledFormPeriod of reportDescriptionDetailsDocument
2009-11-238-K2009-11-175.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events5.02 On November 17, 2009, the Board of Directors of PharMerica Corporation (the “Company”), upon the recommendation of the Nominating and Governance Committee, appointed Geoffrey G. Meyers as a new director effective as of November 17, 2009.
8.01 On November 20, 2009, the Company issued a press release announcing the appointment of Geoffrey G. Meyers as a new director.
d8k.htm
2009-10-298-K2009-10-292.02 Results of Operations and Financial Conditiona6087121.htm
2009-08-038-K2009-08-032.02 Results of Operations and Financial Conditiona6020879.htm
2009-04-308-K2009-04-302.02 Results of Operations and Financial Conditiona5953746.htm
2009-04-218-K2009-04-205.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On April 20, 2009, William (Bill) E. Monast, age 49, was appointed as Executive Vice President, Operations of PharMerica Corporation (the “Company”).d8k.htm
2009-03-098-K2009-03-035.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On March 3, 2009, the Compensation Committee of the Board of Directors of PharMerica Corporation (the “Corporation”) adopted the 2009 Short-Term Incentive Program (the “STIP”) under the PharMerica Corporation 2007 Omnibus Incentive Plan, as amended (the “Omnibus Plan”).d8k.htm
2009-02-058-K2009-02-052.02 Results of Operations and Financial Conditiona5889620.htm
2009-01-278-K2009-01-225.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On January 22, 2009, the Board of Directors of PharMerica Corporation (the “Company”), upon the recommendation of the Nominating and Governance Committee, appointed Marjorie W. Dorr as a new director effective as of January 22, 2009.d8k.htm